AACE 2026: AI moves from hype to reality in diabetes care

"Right now, AI is more of a copilot, but the long-term vision is something much closer to autopilot."

To explore the integration of AI technologies in diabetes management and their clinical relevance.

AI is already showing measurable A1C reductions and improved patient engagement.
Assistive AI tools will dominate near-term adoption, maintaining clinician involvement.
Diabetes management is particularly suited for AI due to high-frequency data and clear outcome metrics.
AI's ability to provide personalized nudges may significantly improve patient adherence.
Fully autonomous AI management remains a future goal, with ongoing advancements in neural networks.

AI is becoming a central component in diabetes management, transitioning from a supportive role to a more autonomous future.

Current AI tools require clinician oversight for safety and regulatory compliance.
Fully independent AI systems are not yet available.

AI is evolving in diabetes care, with the potential to enhance patient management and outcomes significantly.